| Effect of azithromycin on airflow decline–free survival after allogeneic hematopoietic stem cell transplant: the ALLOZITHRO randomized clinical trial A Bergeron, S Chevret, A Granata, P Chevallier, L Vincent, A Huynh, ... Jama 318 (6), 557-566, 2017 | 105 | 2017 |
| Midostaurin in advanced systemic mastocytosis MO Chandesris, G Damaj, D Canioni, C Brouzes, L Lhermitte, ... New England Journal of Medicine 374 (26), 2605-2606, 2016 | 74 | 2016 |
| Mutational profile and benefit of gemtuzumab ozogamicin in acute myeloid leukemia E Fournier, N Duployez, B Ducourneau, E Raffoux, P Turlure, D Caillot, ... Blood, The Journal of the American Society of Hematology 135 (8), 542-546, 2020 | 73 | 2020 |
| Sequential conditioning with thiotepa in T cell-replete hematopoietic stem cell transplantation for the treatment of refractory hematologic malignancies: comparison with … R Duléry, AL Ménard, S Chantepie, J El-Cheikh, S François, J Delage, ... Biology of Blood and Marrow Transplantation 24 (5), 1013-1021, 2018 | 70 | 2018 |
| The level of blast CD33 expression positively impacts the effect of gemtuzumab ozogamicin in patients with acute myeloid leukemia G Olombel, E Guerin, J Guy, JY Perrot, F Dumezy, A de Labarthe, ... Blood, The Journal of the American Society of Hematology 127 (17), 2157-2160, 2016 | 70 | 2016 |
| Added prognostic value of secondary AML-like gene mutations in ELN intermediate-risk older AML: ALFA-1200 study results C Gardin, C Pautas, E Fournier, R Itzykson, E Lemasle, JH Bourhis, ... Blood advances 4 (9), 1942-1949, 2020 | 66 | 2020 |
| Antibody response after 2 and 3 doses of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic cell transplant recipients A Maillard, R Redjoul, M Klemencie, H Labussière Wallet, A Le Bourgeois, ... Blood, The Journal of the American Society of Hematology 139 (1), 134-137, 2022 | 63 | 2022 |
| Sorafenib improves survival of FLT3-mutated acute myeloid leukemia in relapse after allogeneic stem cell transplantation: a report of the EBMT Acute Leukemia Working Party A Bazarbachi, M Labopin, G Battipaglia, A Djabali, J Passweg, G Socié, ... Haematologica 104 (9), e398, 2019 | 56 | 2019 |
| 5‐Azacytidine treatment for relapsed or refractory acute myeloid leukemia after intensive chemotherapy S Ivanoff, B Gruson, SP Chantepie, E Lemasle, L Merlusca, V Harrivel, ... American Journal of Hematology 88 (7), 601-605, 2013 | 54 | 2013 |
| Hematogones: an overview SP Chantepie, E Cornet, V Salaün, O Reman Leukemia Research 37 (11), 1404-1411, 2013 | 51 | 2013 |
| Genetic identification of patients with AML older than 60 years achieving long-term survival with intensive chemotherapy R Itzykson, E Fournier, C Berthon, C Röllig, T Braun, A Marceau-Renaut, ... Blood, The Journal of the American Society of Hematology 138 (7), 507-519, 2021 | 46 | 2021 |
| Rare but authentic Philadelphia-positive acute myeloblastic leukemia: two case reports and a literature review of characteristics, treatment and outcome E Reboursiere, S Chantepie, AC Gac, O Reman Hematology/Oncology and Stem Cell Therapy 8 (1), 28-33, 2015 | 45 | 2015 |
| Bendamustine‐based conditioning prior to autologous stem cell transplantation (ASCT): results of a French multicenter study of 474 patients from LYmphoma Study Association … SP Chantepie, S Garciaz, E Tchernonog, F Peyrade, MV Larcher, M Diouf, ... American journal of hematology 93 (6), 729-735, 2018 | 44 | 2018 |
| Severe chronic primary neutropenia in adults: report on a series of 108 patients F Sicre de Fontbrune, A Moignet, B Beaupain, F Suarez, L Galicier, ... Blood, The Journal of the American Society of Hematology 126 (14), 1643-1650, 2015 | 44 | 2015 |
| Prognostic significance of concurrent gene mutations in intensively treated patients with IDH-mutated AML: an ALFA study M Duchmann, JB Micol, N Duployez, E Raffoux, X Thomas, JP Marolleau, ... Blood, The Journal of the American Society of Hematology 137 (20), 2827-2837, 2021 | 42 | 2021 |
| A personalized approach to guide allogeneic stem cell transplantation in younger adults with acute myeloid leukemia L Fenwarth, X Thomas, S De Botton, N Duployez, JH Bourhis, A Lesieur, ... Blood, The Journal of the American Society of Hematology 137 (4), 524-532, 2021 | 42 | 2021 |
| Fractionated doses of gemtuzumab ozogamicin with escalated doses of daunorubicin and cytarabine as first acute myeloid leukemia salvage in patients aged 50–70‐year old: A phase … H Farhat, O Reman, E Raffoux, C Berthon, C Pautas, L Kammoun, ... American journal of hematology 87 (1), 62-65, 2012 | 41 | 2012 |
| Hematogones: a new prognostic factor for acute myeloblastic leukemia SP Chantepie, V Salaün, JJ Parienti, F Truquet, M Macro, S Cheze, ... Blood, The Journal of the American Society of Hematology 117 (4), 1315-1318, 2011 | 40 | 2011 |
| Dynamics of procalcitonin and bacteremia in neutropenic adults with acute myeloid leukemia AC Gac, JJ Parienti, S Chantepie, S Fradin, X Le Coutour, R Leclercq, ... Leukemia research 35 (10), 1294-1296, 2011 | 39 | 2011 |
| Rituximab-based first-line treatment of cGVHD after allogeneic SCT: results of a phase 2 study F Malard, M Labopin, I Yakoub-Agha, S Chantepie, T Guillaume, D Blaise, ... Blood, The Journal of the American Society of Hematology 130 (20), 2186-2195, 2017 | 38 | 2017 |
